|
| Exchange Disseminated Time | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has:
1. Recommended dividend of Re. 1.00(10%) per Equity Share of face value Rs. 10/- each.
2. Allotted 36,89,200 warrants convertible in to equal number of Equity shares on preferential basis to the promoters / promoters' group and persons other than the promoters / promoters’ group pursuant to the Securities And Exchange Board of India (Issue Of Capital And Disclosure Requirements) Regulations, 2009.
3. Approved and adopted the Code of Conduct for prohibition of Insider Trading as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015. |
|
|